Differential effects of MAPK pathway inhibitors on migration and invasiveness of BRAF(V600E) mutant thyroid cancer cells in 2D and 3D culture

Exp Cell Res. 2015 Nov 1;338(2):127-35. doi: 10.1016/j.yexcr.2015.08.003. Epub 2015 Sep 15.

Abstract

Tumor microenvironment influences targeted drug therapy. In this study we compared drug responses to RAF and MEK inhibitors on tumor cell migration in 2D and 3D culture of BRAF(V600E) mutant cell lines derived from human papillary (BCPAP) and anaplastic (SW1736) thyroid carcinomas. Scratch wounding was compared to a double-layered collagen gel model developed for analysis of directed tumor cell invasion during prolonged culture. In BCPAP both PLX4720 and U0126 inhibited growth and migration in 2D and decreased tumor cell survival in 3D. In SW1736 drugs had no effect on migration in 2D but decreased invasion in 3D, however this related to reduced growth. Dual inhibition of BRAF(V600E) and MEK reduced but did not prevent SW1736 invasion although rebound phosphorylation of ERK in response to PLX4720 was blocked by U0126. These findings indicate that anti-tumor drug effects in vitro differ depending on culture conditions (2D vs. 3D) and that the invasive features of anaplastic thyroid cancer depend on non-MEK mechanism(s).

Keywords: 3D; BRAF; Cancer; MEK; Migration; PLX4720; Thyroid; U0126.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / pharmacology
  • Butadienes / pharmacology
  • Carcinoma / drug therapy
  • Carcinoma / genetics
  • Cell Culture Techniques / methods
  • Cell Line, Tumor
  • Cell Movement / drug effects*
  • Cell Movement / genetics
  • Cell Survival / drug effects
  • Cell Survival / genetics
  • Humans
  • Indoles / pharmacology
  • Mitogen-Activated Protein Kinases / antagonists & inhibitors*
  • Mitogen-Activated Protein Kinases / genetics
  • Mutation / drug effects
  • Mutation / genetics
  • Neoplasm Invasiveness / genetics
  • Neoplasm Invasiveness / pathology*
  • Nitriles / pharmacology
  • Phosphorylation / drug effects
  • Protein Kinase Inhibitors / pharmacology*
  • Proto-Oncogene Proteins B-raf / genetics*
  • Signal Transduction / drug effects*
  • Signal Transduction / genetics
  • Sulfonamides / pharmacology
  • Thyroid Carcinoma, Anaplastic / drug therapy*
  • Thyroid Carcinoma, Anaplastic / genetics

Substances

  • Antineoplastic Agents
  • Butadienes
  • Indoles
  • Nitriles
  • PLX 4720
  • Protein Kinase Inhibitors
  • Sulfonamides
  • U 0126
  • BRAF protein, human
  • Proto-Oncogene Proteins B-raf
  • Mitogen-Activated Protein Kinases